Supporting India amid COVID-19 surge
EVA Pharma signed a contract with the Indian government to export 300,000 vials of Remdesivir. EVA Pharma’s ( www.EVAPharma.com ) timely shipments of Remdesivir reached India during a major wave of coronavirus cases. When India experienced an unexpected COVID-19 surge this spring, the rapid increase in cases put pressure on the local pharmaceutical industry to supply the medicines needed. In April, EVA Pharma signed a contract with the Indian government to export 300,000 vials of Remdesivir, an approved treatment for coronavirus, to meet the urgent needs there. Six shipments of Remdesivir were flown to Mumbai between May and June and were subsequently dispatched to hospitals across India, reaching patients everywhere from major cities to the remote archipelago of Lakshadweep. “I’m glad to say that the six consignments in which the Remdesivir was dispatched to India were not only sent on schedule but in all cases before the schedule,” commented Ambassador Ajit Gupte, India’s envoy to